Failure of Chemotherapy in Hepatocellular Carcinoma Due to Impaired and Dysregulated Primary Liver Drug Metabolizing Enzymes and Drug Transport Proteins: What to Do?
CONCLUSION: The future of HCC treatment should emphasize the understanding of resistance mechanisms and the finding of novel, safe, and efficacious therapeutic strategies, which will surely benefit patients affected by advanced HCC.
PMID: 29807513 [PubMed - as supplied by publisher]
Source: Current Drug Metabolism - Category: Drugs & Pharmacology Authors: Ul Islam S, Ahmed MB, Shehzad A, Ul-Islam M, Lee YS Tags: Curr Drug Metab Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Drugs & Pharmacology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Transplants | Urology & Nephrology | Vaccines